Wisevoter
U.S.

Nicotine Startup Skoka Raises $21.5 Million in Funding

The company has filed a bundled Premarket Tobacco Product Application with the FDA for 55 new products.

Updated on Oct. 30, 2026 in Startups

Isometric editorial illustration featuring a grid of fifty-five identical industrial laboratory vials, representing regulatory filings and product development.
Nicotine startup Skoka raised $21.5 million in a new funding round and filed a bundled application for 55 products with the FDA. AI Illustration. Upload story photo >

Live Poll

Should the government allow the retail sale of new nicotine pouch brands?

Nicotine startup Skoka has secured $21.5 million in capital from professional athletes and executives. The company also submitted a bundled Premarket Tobacco Product Application to the FDA covering 55 distinct products.

Why it matters

The funding and FDA application represent a significant step for the 2024 startup as it seeks to enter the nicotine market. Skoka is specifically focusing its development on adult nicotine consumers aged 21 and older.

Skoka raised $21.5 million to support its operations and filed for FDA approval of 55 products across 11 varieties and five strengths. The regulatory application covers a diverse product suite intended for the U.S. market.

The players

Skoka

This is a nicotine startup founded in 2024 that targets adult consumers aged 21 and older.

Dan Aziz

He is the founder of the nicotine startup Skoka.

Food and Drug Administration

This federal agency is responsible for reviewing Premarket Tobacco Product Applications to authorize the sale of new tobacco and nicotine products.

The details

Founded by Dan Aziz, the company attracted investment from various professional athletes and executives who contributed their own capital. Skoka aims to serve the adult nicotine market with its planned product lineup.

Timeline

  1. Skoka was founded in 2024.

  2. On October 30, 2026, the company announced its funding and PMTA submission.

  3. The company plans to launch U.S. retail distribution in 2027.

Market Landscape

The firm is aligning its growth strategy with the regulatory hurdles defined by the FDA's Premarket Tobacco Product Application process. This move positions the startup within the highly regulated landscape of nicotine product commercialization.

Adult nicotine consumers aged 21 and older will see these products reach retail shelves once the FDA completes its review process. The company aims to make its 55 distinct product offerings available to the market by 2027.

The takeaway

The startup is banking on a large-scale product bundle to capture the adult nicotine market. Interested stakeholders should watch for future regulatory updates from the FDA regarding the submitted application.

What happens next

The company expects to initiate retail distribution throughout the United States in 2027.

Further reading

Explore more industry developments in the Startups section.

Source note: This article includes information reported by Vcnewsdaily.

Live Poll

Should the government allow the retail sale of new nicotine pouch brands?